Lotto 1
Original notice title
Bando SDA FARMACI EMODERIVATI SOLUZIONI INFUSIONALI VACCINI E MEZZI DI CONTRASTO prima edizione
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
65 / 100
Risk factors
Restricted procedure means only pre-qualified suppliers can bid on specific contracts; initial qualification may be com...
Procurement documents are available but were not analyzed; there may be hidden requirements.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- EUR 3500M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 1460 DAY
- Supply of pharmaceutical products (blood-derived drugs, infusion solutions, vaccines, contrast media)
- DPS covering a period of 1460 days (approx. 4 years)
Show full summary
This tender is a Dynamic Purchasing System (DPS) for pharmaceutical products (blood-derived drugs, infusion solutions, vaccines, and contrast media) issued by PuntoZero s.c.a.r.l. on behalf of Italian healthcare entities. It is a restricted procedure with a single lot, valued at €3.5 billion, covering a 4-year period. The award is based solely on price. The tender is published in Italian, with submission required electronically via the provided platform. The deadline for submission is October 1, 2029. Key eligibility includes registration with professional/commercial registers and certifications for quality and environmental management.
Risks
Restricted procedure means only pre-qualified suppliers can bid on specific contracts; initial qualification may be com...
Procurement documents are available but were not analyzed; there may be hidden requirements.
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Restricted procedure – only pre-selected suppliers may bid on specific contracts
Administrative
- DPS participation requires registration on the platform (Aura)
- Submission must be electronic via Open portal
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Name
PuntoZero s.c.a.r.l.
Location
Perugia, ITA
Buyer profile
Identifier
02915750547
Lots (1)
LOT-0001
Lotto 1
Procurement of pharmaceutical products including blood-derived drugs, infusion solutions, vaccines, and contrast media.
EUR 3.5B
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
Lotto 1
Procurement Details
- Publication date
- 29 Sep 2025
- Notice type
- Contract notice — standard
- Languages
- Italian
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 636806-2025
- Source notice ID
- 71069680-1aeb-4faf-88aa-d6318e461dac
Documents (2)
Similar tenders
Denmark – Pharmaceutical products – Amgros 2027 1.1051.b
Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie
Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE
Denmark – Pharmaceutical products – Amgros 2027 1.1052.b
Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem
Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
65 / 100
Risk factors
Restricted procedure means only pre-qualified suppliers can bid on specific contracts; initial qualification may be com...
Procurement documents are available but were not analyzed; there may be hidden requirements.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications